|
INADL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.176000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.885400E-01 |
| Normal-vs-Stage2 |
1.090180E-01 |
| Normal-vs-Stage3 |
3.247400E-01 |
| Normal-vs-Stage4 |
2.891800E-01 |
| Stage1-vs-Stage2 |
8.088400E-02 |
| Stage1-vs-Stage3 |
1.980590E-01 |
| Stage1-vs-Stage4 |
1.889960E-01 |
| Stage2-vs-Stage3 |
4.443400E-01 |
| Stage2-vs-Stage4 |
4.645200E-01 |
| Stage3-vs-Stage4 |
9.799200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.265800E-01 |
| Normal-vs-AfricanAmerican |
1.788850E-01 |
| Normal-vs-Asian |
4.805400E-01 |
| Caucasian-vs-AfricanAmerican |
6.384100E-02 |
| Caucasian-vs-Asian |
1.507630E-01 |
| AfricanAmerican-vs-Asian |
5.199000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.257200E-01 |
| Normal-vs-Female |
6.617400E-01 |
| Male-vs-Female |
3.861600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.424600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.384800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.224600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.237600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.761900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.700180E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.861100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.666200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.254000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.725600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.368400E-02 |
| Classical-VS-Follicular |
1.08769999995761E-06 |
| Classical-VS-Other |
4.618600E-01 |
| Classical-VS-Normal |
4.730800E-01 |
| Tall-VS-Follicular |
2.614400E-01 |
| Tall-VS-Other |
7.931000E-01 |
| Tall-VS-Normal |
1.732020E-01 |
| Follicular-VS-Other |
4.068800E-01 |
| Follicular-VS-Normal |
4.459700E-03 |
| Other-VS-Normal |
6.266800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390040E-01 |
| Normal-vs-N1 |
6.763200E-01 |
| N0-vs-N1 |
4.608400E-01 |
|
|
